Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NKGen Biotech (NKGN)
NASDAQ:NKGN
Holding NKGN?
Track your performance easily
NKGN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.20 - $4.06
Previous CloseN/A
Volume116.73K
Average Volume (3M)366.91K
Market Cap
$18.35M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.72M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.49
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.92
Shares Outstanding35,524,376
10 Day Avg. Volume261,765
30 Day Avg. Volume366,914
Standard Deviation0.32
R-Squared0.00660
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
NKGen Biotech News
PremiumCompany Announcements
NKGen Biotech Awards Stock Options to Executives
PremiumCompany Announcements
NKGen Biotech Secures Key Role in NKMax Deal
PremiumCompany Announcements
NKGen Biotech Faces Delisting Notice Amid Reporting Delay
PremiumCompany Announcements
NKGen Biotech Welcomes New Directors and Assigns Committees
PremiumCompany Announcements
NKGen Biotech Announces Leadership Shuffle on AnniversaryOwnership Overview
13.21% Insiders
0.83% Mutual Funds
9.05% Other Institutional Investors
76.24% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NKGN FAQ
What was NKGen Biotech’s price range in the past 12 months?
NKGen Biotech lowest stock price was $0.20 and its highest was $4.06 in the past 12 months.
What is NKGen Biotech’s market cap?
NKGen Biotech’s market cap is $18.35M.
When is NKGen Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NKGen Biotech’s earnings last quarter?
NKGen Biotech released its earnings results on Nov 14, 2023. The company reported -$2.476 earnings per share for the quarter, missing the consensus estimate of N/A by -$2.476.
Is NKGen Biotech overvalued?
According to Wall Street analysts NKGen Biotech’s price is currently Overvalued.
Does NKGen Biotech pay dividends?
NKGen Biotech does not currently pay dividends.
What is NKGen Biotech’s EPS estimate?
NKGen Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NKGen Biotech have?
NKGen Biotech has 35,524,376 shares outstanding.
What happened to NKGen Biotech’s price movement after its last earnings report?
NKGen Biotech reported an EPS of -$2.476 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.35%.
Which hedge fund is a major shareholder of NKGen Biotech?
Currently, no hedge funds are holding shares in NKGN
---
Company Description
NKGen Biotech
Graf Acquisition Corp IV is a newly organized blank check company. It is formed for the purpose of effecting into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses.
---
Technical Analysis
Bluebird Bio
―
Fate Therapeutics
―
Karyopharm Therapeutics
―
CryoPort
―
Adaptimmune Therapeutics
―
---